```html

Y‑90 Radioembolization Complications – A Complete Patient Guide

Overview

Y‑90 radioembolization (also called Selective Internal Radiation Therapy or SIRT) is a minimally invasive procedure in which tiny glass or resin beads loaded with the radioactive isotope yttrium‑90 (Y‑90) are delivered through a catheter into the hepatic artery that supplies a liver tumor. The beads lodge in the tumor’s micro‑vasculature and emit high‑energy beta radiation, destroying cancer cells while sparing most of the surrounding healthy liver tissue.

Who it affects: Y‑90 is most commonly used for primary liver cancers such as hepatocellular carcinoma (HCC) and for metastatic disease that has spread to the liver from colorectal, breast, or neuroendocrine tumors.

Prevalence: In the United States, >30,000 Y‑90 procedures are performed each year, with an overall complication rate of 15–20 % (Mayo Clinic; mayoclinic.org). Most complications are mild and self‑limited, but serious adverse events (e.g., radiation‑induced liver disease) occur in < 5 % of patients.

Symptoms

Complications can manifest immediately after the procedure or weeks to months later. Below is a comprehensive list of reported symptoms, grouped by the organ system most commonly involved.

General / Constitutional

• Fever or chills – usually low‑grade, indicating an inflammatory response.
• Fatigue – common after any radiation‑based therapy.
• Weight loss – may reflect decreased appetite or underlying disease progression.

Gastro‑intestinal (GI) tract

• Nausea / vomiting – can begin within 24 h and last several days.
• Abdominal pain – often dull or cramping in the right upper quadrant.
• Diarrhea or loose stools – especially if embolic particles reflux into the gastroduodenal artery.
• Gastric ulcer or gastritis – may present with epigastric pain, melena, or hematemesis.
• Radiation‑induced colitis – rare, presents with bloody diarrhea and urgency.

Liver‑specific

• Elevated liver enzymes (ALT, AST, bilirubin) – a laboratory marker of liver injury.
• Right‑upper‑quadrant tenderness – may indicate hepatic ischemia or tumor necrosis.
• Ascites – fluid accumulation secondary to liver dysfunction.
• Radiation‑induced liver disease (RILD) – presents with anicteric ascites, hepatomegaly, and worsening labs.

Vascular / Pulmonary

• Shortness of breath – can result from inadvertent shunting of Y‑90 particles to the lungs.
• Cough or hemoptysis – rare, signals pulmonary radiation injury.

Neurologic / Systemic

• Fever of unknown origin – may indicate infection (e.g., cholangitis) after the procedure.
• Sepsis – rare but life‑threatening, usually linked to biliary infection.

Causes and Risk Factors

Complications arise when radiation, embolic material, or procedural factors affect non‑target tissues.

Procedural causes

• Non‑target embolization – Y‑90 beads travel to the stomach, duodenum, pancreas, or lungs.
• High radiation dose to normal liver – excessive absorbed dose (>30 Gy) increases risk of RILD.
• Catheter manipulation injury – arterial dissection or spasm can cause bleeding.

Patient‑related risk factors

• Pre‑existing liver dysfunction (Child‑Pugh B/C).
• Portal vein thrombosis – reduces collateral flow, concentrating radiation.
• Severe biliary obstruction – higher chance of infection after embolization.
• Previous liver radiation or chemotherapy (e.g., sorafenib).
• Large tumor burden (>50 % of liver volume).

Diagnosis

Identifying a complication begins with a thorough history, physical exam, and targeted investigations.

Laboratory tests

• Complete metabolic panel – focus on ALT, AST, alkaline phosphatase, bilirubin.
• Complete blood count – monitor for leukocytosis (infection) or anemia (bleeding).
• Coagulation profile – essential before any invasive follow‑up.

Imaging studies

• Triphasic contrast CT or MRI of the liver – assesses tumor response, identifies non‑target injury, or RILD.
• 99mTc‑macroaggregated albumin (MAA) scan – performed before therapy to predict lung shunt fraction; repeat if symptoms suggest pulmonary involvement.
• Chest CT – if respiratory symptoms develop, to rule out pulmonary emboli or radiation pneumonitis.
• Upper endoscopy (EGD) – indicated for unexplained GI bleeding or suspected gastritis/ulcer.

Functional assessments

• Liver stiffness measurement (FibroScan) – helps gauge baseline hepatic reserve.
• Quality‑of‑life questionnaires (e.g., EORTC QLQ‑C30) – useful for tracking symptom burden over time.

Treatment Options

Management is tailored to the specific complication, severity, and the patient’s overall health.

Medication‑based interventions

• Analgesics – acetaminophen or short courses of opioids for severe pain (avoid NSAIDs if liver function is compromised).
• Anti‑emetics – ondansetron, metoclopramide, or prochlorperazine for nausea/vomiting.
• Proton‑pump inhibitors (PPIs) or H2 blockers – for gastritis/ulcer prophylaxis.
• Corticosteroids – low‑dose prednisone (0.5–1 mg/kg) can mitigate inflammation in RILD or radiation colitis.
• Antibiotics – broad‑spectrum coverage (e.g., ceftriaxone + metronidazole) for cholangitis or sepsis.
• Diuretics (spironolactone, furosemide) – for ascites secondary to liver dysfunction.

Procedural / Interventional measures

• Endoscopic hemostasis – clipping, thermal coagulation, or injection for bleeding ulcers.
• Transjugular intrahepatic portosystemic shunt (TIPS) – reserved for refractory ascites or variceal bleeding.
• Bronchoscopy – rare pulmonary hemorrhage may require localized therapy.
• Repeat angiography – can identify and embolize inadvertent non‑target vessels.

Lifestyle & supportive care

• Low‑sodium diet (≤2 g Na⁺/day) to reduce ascites.
• Hydration and small, frequent meals to ease GI upset.
• Avoid alcohol and hepatotoxic drugs (e.g., high‑dose acetaminophen).
• Physical activity as tolerated – walking improves circulation and mood.

Living with Y‑90 Radioembolization Complications

Adapting to post‑procedure life focuses on monitoring, symptom control, and maintaining liver health.

Daily self‑monitoring

• Check body temperature once daily; fever ≥38.0 °C warrants contact with your care team.
• Record weight; a gain of >2 kg in a week could signal ascites.
• Track abdominal pain intensity (0–10 scale) and note triggers.
• Observe stool color and consistency – black/tarry stools may indicate GI bleeding.

Medication adherence

Set reminders for PPIs, diuretics, and any prescribed steroids. Never stop steroids abruptly; taper per physician instructions.

Nutritional tips

• Prioritize high‑protein foods (lean meat, beans, dairy) to support liver regeneration.
• Include antioxidant‑rich fruits (berries) and vegetables (leafy greens) to combat oxidative stress.
• Limit processed foods, sugars, and saturated fats, which can worsen hepatic steatosis.

Psychosocial support

Living with cancer‑related complications can be stressful. Consider:

• Joining a liver‑cancer support group (online or in‑person).
• Speaking with a mental‑health professional for anxiety or depression.
• Utilizing patient portals for quick communication with your oncologist.

Prevention

Many complications are preventable with careful pre‑procedural planning and post‑procedure care.

• Comprehensive pre‑treatment mapping – MAA scan to quantify lung shunt fraction; aim for < 20 % to keep pulmonary dose <30 Gy.
• Selective catheterization – using micro‑catheters and cone‑beam CT to avoid non‑target embolization.
• Prophylactic PPIs – reduce risk of gastritis/ulcer when high gastric shunting is anticipated.
• Optimizing liver function – correct coagulopathy, treat biliary obstruction, and ensure adequate nutrition before the procedure.
• Close post‑procedure monitoring – labs at 24 h, 1 week, and monthly for the first 3 months.
• Patient education – clear instructions on warning signs and when to call the treatment center.

Complications if Untreated

While many side effects are self‑limited, failure to address them can lead to serious sequelae:

• Progressive liver failure – untreated RILD may evolve to hepatic encephalopathy and need transplantation.
• Bleeding – gastric or duodenal ulcers can cause massive hemorrhage, requiring transfusion or surgery.
• Infection – cholangitis or intra‑abdominal abscesses can become septic, with a mortality rate up to 30 % if not promptly treated.
• Pulmonary fibrosis – radiation pneumonitis left unmanaged can progress to irreversible fibrosis.
• Quality‑of‑life deterioration – chronic pain, fatigue, and ascites limit daily activities and can worsen depression.

When to Seek Emergency Care

Prompt medical attention can prevent progression to life‑threatening conditions and improve outcomes.

---

Sources: Mayo Clinic. “Yttrium-90 Radioembolization (SIRT).” mayoclinic.org; Cleveland Clinic. “Complications of Radioembolization.” my.clevelandclinic.org; National Cancer Institute. “Radioembolization (SIRT) – patient information.” cancer.gov; American College of Radiology. “ACR Appropriateness Criteria: Y‑90 Radioembolization.”; World Health Organization. “Radiation safety and liver cancer.” who.int.

```